Press & Statements

CSRxP STATEMENT ON THE PASSING OF DAVID MITCHELL

Jan 5, 2026

Founder and President of Patients for Affordable Drugs Was a Tireless and Read More

CSRxP: BIG PHARMA RINGS IN 2026 WITH MORE THAN 300 PRICE INCREASES ON BRAND NAME DRUGS, OUTPACING START OF 2025

Jan 5, 2026

Big Pharma Giants Including Pfizer and GSK Kickoff a New Year with Price Hikes Read More

CSRxP APPLAUDS ADMINISTRATION FOR COMMITMENT TO FOSTERING GREATER BIOSIMILAR COMPETITION, LOWERING DRUG PRICES FOR AMERICAN PATIENTS

Oct 29, 2025

Efforts to Eliminate Red Tape and Boost Access to More Affordable Alternatives Read More

CSRxP: PERA WOULD FURTHER ENABLE BIG PHARMA’S PATENT ABUSE THAT KEEPS PRESCRIPTION DRUG PRICES HIGH

Oct 7, 2025

Senate Judiciary Lawmakers Should Reject Big Pharma-Backed Proposal and Read More

U.S. HOUSE COMMITTEE SHOULD ADVANCE Q1/Q2 REFORMS TO PROMOTE GREATER COMPETITION AND HELP LOWER PRESCRIPTION DRUG PRICES

Sep 17, 2025

Lawmakers Should Advance Bipartisan, Market-Based Solution to Crack Down on Read More